Literature DB >> 28013393

NGF/anti-VEGF combined exposure protects RCS retinal cells and photoreceptors that underwent a local worsening of inflammation.

Maria Luisa Rocco1, Bijorn Omar Balzamino2, Graziana Esposito2, Carla Petrella1, Luigi Aloe1, Alessandra Micera3.   

Abstract

PURPOSE: Our previous study highlighted the potential nerve growth factor (NGF) effect on damaged photoreceptors from a rat model of spontaneous Retinitis Pigmentosa (RP). Herein, we tested the combined NGF/anti-vascular endothelial growth factor (αVEGF) effect on cultured retinal cells isolated from Royal College of Surgeons (RCS) rats receiving an intravitreal VEGF injection (iv-VEGF) to exacerbate retinal inflammation/neovascularization.
METHODS: RCS (n = 75) rats were equally grouped as untreated (n = 25), iv-saline (single saline intravitreal injection; n = 25) and iv-VEGF (single VEGF intravitreal injection; n = 25). Morphological and biochemical analysis or in vitro stimulations with the biomolecular investigation were carried out on explanted retinas. Isolated retinal cells were treated with NGF and αVEGF, either alone or in combination, for 6 days and cells were harvested for morphological and biomolecular analyses.
RESULTS: Infiltrating inflammatory cells were detected in iv-VEGF exposed RCS retinas, indicative of exacerbated inflammation and neovascularization. In cell cultures, NGFVEGF significantly increased retinal cell survival as well as rhodopsin expression and neurite outgrowth in photoreceptors. Particularly, NGFVEGF upregulated Bcl-2 mRNA, downregulated Bax mRNA, upregulated trkANGFR mRNA and finally upregulated both NGF mRNA and protein.
CONCLUSIONS: These data confirm and extend our previous findings on NGF-photoreceptor crosstalk, highlighting that the NGFVEGF combination might be an interesting approach for improving neuroprotection of RCS retinal cells and likewise photoreceptors in the presence of neovascularization. Further studies are required to translate this in vitro approach into clinical practice.

Entities:  

Keywords:  Anti-VEGF; Apoptosis; NGF; Neuroprotection; Retinal degeneration; Retinitis pigmentosa

Mesh:

Substances:

Year:  2016        PMID: 28013393     DOI: 10.1007/s00417-016-3567-8

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  58 in total

1.  Effect of hypergravity on the mouse basal expression of NGF and BDNF in the retina, visual cortex and geniculate nucleus: correlative aspects with NPY immunoreactivity.

Authors:  L Aloe; M Fiore; D Santucci; T Amendola; A Antonelli; N Francia; G Corazzi; E Alleva
Journal:  Neurosci Lett       Date:  2001-04-13       Impact factor: 3.046

Review 2.  Clinical applications of NGF in ocular diseases.

Authors:  Alessandro Lambiase; Flavio Mantelli; Marta Sacchetti; Simona Rossi; Luigi Aloe; Stefano Bonini
Journal:  Arch Ital Biol       Date:  2011-06       Impact factor: 1.000

3.  A Simple Spontaneous Vitreal Reflux Collecting Procedure During Intravitreal Injection: Set-Up and Validation Studies.

Authors:  Andrea Cacciamani; Mariacristina Parravano; Fabio Scarinci; Graziana Esposito; Monica Varano; Alessandra Micera
Journal:  Curr Eye Res       Date:  2015-10-15       Impact factor: 2.424

4.  Effect of exogenous administration of nerve growth factor in the retina of rats with inherited retinitis pigmentosa.

Authors:  Laura Lenzi; Marco Coassin; Alessandro Lambiase; Stefano Bonini; Tiziana Amendola; Luigi Aloe
Journal:  Vision Res       Date:  2005-06       Impact factor: 1.886

Review 5.  Vascular endothelial growth factors and angiogenesis in eye disease.

Authors:  A N Witmer; G F J M Vrensen; C J F Van Noorden; R O Schlingemann
Journal:  Prog Retin Eye Res       Date:  2003-01       Impact factor: 21.198

6.  Reduced NGF level and TrkA protein and TrkA gene expression in the optic nerve of rats with experimentally induced glaucoma.

Authors:  Valentina Sposato; Massimo Gilberto Bucci; Marco Coassin; Matteo Antonio Russo; Alessandro Lambiase; Luigi Aloe
Journal:  Neurosci Lett       Date:  2008-09-18       Impact factor: 3.046

7.  Capsaicin-induced corneal sensory denervation and healing impairment are reversed by NGF treatment.

Authors:  Alessandro Lambiase; Luigi Aloe; Flavio Mantelli; Marta Sacchetti; Eleonora Perrella; Patrizia Bianchi; Maria Luisa Rocco; Stefano Bonini
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-12-17       Impact factor: 4.799

8.  Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury.

Authors:  Kazuaki Nishijima; Yin-Shan Ng; Lichun Zhong; John Bradley; William Schubert; Nobuo Jo; Jo Akita; Steven J Samuelsson; Gregory S Robinson; Anthony P Adamis; David T Shima
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

Review 9.  The nerve growth factor signaling and its potential as therapeutic target for glaucoma.

Authors:  Haitao Wang; Rikang Wang; Thilini Thrimawithana; Peter J Little; Jiangping Xu; Zhong-Ping Feng; Wenhua Zheng
Journal:  Biomed Res Int       Date:  2014-08-31       Impact factor: 3.411

10.  NGF eye-drops topical administration in patients with retinitis pigmentosa, a pilot study.

Authors:  Benedetto Falsini; Giancarlo Iarossi; Antonio Chiaretti; Antonio Ruggiero; Luigi Manni; Manni Luigi; Lucia Galli-Resta; Giovanni Corbo; Edoardo Abed
Journal:  J Transl Med       Date:  2016-01-09       Impact factor: 5.531

View more
  3 in total

1.  Changes in vitreal protein profile and retina mRNAs in Reeler mice: NGF, IL33 and Müller cell activation.

Authors:  Bijorn Omar Balzamino; Graziana Esposito; Ramona Marino; Flavio Keller; Alessandra Micera
Journal:  PLoS One       Date:  2019-02-27       Impact factor: 3.240

2.  Phagosomal and mitochondrial alterations in RPE may contribute to KCNJ13 retinopathy.

Authors:  Maria Toms; Thomas Burgoyne; Dhani Tracey-White; Rose Richardson; Adam M Dubis; Andrew R Webster; Clare Futter; Mariya Moosajee
Journal:  Sci Rep       Date:  2019-03-07       Impact factor: 4.379

Review 3.  Biomarkers of Neurodegeneration and Precision Therapy in Retinal Disease.

Authors:  Alessandra Micera; Bijorn Omar Balzamino; Antonio Di Zazzo; Lucia Dinice; Stefano Bonini; Marco Coassin
Journal:  Front Pharmacol       Date:  2021-01-18       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.